AI assistant
Sending…
Nuvation Bio Inc. — Director's Dealing 2024
Oct 9, 2024
32154_dirs_2024-10-09_259f6806-7780-46e0-be56-81b17f7fcedf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2024-10-07
Reporting Person: Sauvage Philippe (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-07 | Stock Option (Right to Buy) | $2.17 | A | 750000 | Acquired | 2034-10-06 | Class A Common Stock (750000) | Direct |
Footnotes
F1: Option vests as to 25% on the one year anniversary of 10/7/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
More from Nuvation Bio Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4